US Patent Issued to MIRATI THERAPEUTICS on March 18 for "Imidazo[1,2-cpyrimidine derivatives as PRC2 inhibitors for treating cancer" (California Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,493, issued on March 18, was assigned to MIRATI THERAPEUTICS INC. (Princeton, N.J.).

"Imidazo[1,2-cpyrimidine derivatives as PRC2 inhibitors for treating cancer" was invented by Matthew Arnold Marx (San Diego), John Michael Ketcham (San Diego) and Aaron Craig Burns (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, disclosed are compounds of Formula (I) and pharmaceutical compositions thereof, and methods of using the compounds and pharmaceutical compositions in, for example, methods of treating cancer."

The patent was filed on June 3, 2020, u...